• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以儿童肺动脉高压体征和症状为表现的结缔组织病。

Connective tissue disease presenting with signs and symptoms of pulmonary hypertension in children.

作者信息

Takatsuki Shinichi, Soep Jennifer B, Calderbank Michelle, Ivy David Dunbar

机构信息

Department of Pediatrics, The Children's Hospital, University of Colorado Denver School of Medicine, 3123 East 16th Avenue, B100, Aurora, CO 80045, USA.

出版信息

Pediatr Cardiol. 2011 Aug;32(6):828-33. doi: 10.1007/s00246-011-9950-7. Epub 2011 Mar 30.

DOI:10.1007/s00246-011-9950-7
PMID:21448619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3142789/
Abstract

Our case series describes three children who were initially diagnosed as having severe pulmonary arterial hypertension (PAH) and subsequently found to be positive for specific autoantibodies suggestive of an underlying autoimmune process. The signs and symptoms of PAH are subtle and may be part of the initial presentation of childhood connective tissue disease (CTD). Evaluation for connective tissue disease in the newly diagnosed pulmonary hypertension (PH) patient is important because early diagnosis of PH as well as CTD is crucial in the successful management of these complex patients. Ongoing monitoring for CTD in patients with severe PAH is warranted.

摘要

我们的病例系列描述了三名儿童,他们最初被诊断为患有重度肺动脉高压(PAH),随后发现特定自身抗体呈阳性,提示存在潜在的自身免疫过程。PAH的体征和症状较为隐匿,可能是儿童结缔组织病(CTD)初始表现的一部分。对新诊断的肺动脉高压(PH)患者进行结缔组织病评估很重要,因为早期诊断PH以及CTD对于成功管理这些复杂患者至关重要。对重度PAH患者进行CTD的持续监测是必要的。

相似文献

1
Connective tissue disease presenting with signs and symptoms of pulmonary hypertension in children.以儿童肺动脉高压体征和症状为表现的结缔组织病。
Pediatr Cardiol. 2011 Aug;32(6):828-33. doi: 10.1007/s00246-011-9950-7. Epub 2011 Mar 30.
2
[Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].[儿童结缔组织病继发肺动脉高压的临床分析]
Zhonghua Er Ke Za Zhi. 2008 Nov;46(11):822-6.
3
Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.心脏磁共振成像、计算机断层扫描和超声心动图在评估结缔组织病患者疑似肺动脉高压中的诊断效用比较。
J Rheumatol. 2012 Jun;39(6):1265-74. doi: 10.3899/jrheum.110987. Epub 2012 May 15.
4
[Recommendations for the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension in China].《中国结缔组织病相关肺动脉高压诊断和治疗推荐意见》
Zhonghua Nei Ke Za Zhi. 2022 Nov 1;61(11):1206-1216. doi: 10.3760/cma.j.cn112138-20220309-00164.
5
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.结缔组织病相关性肺动脉高压:流行病学、发病机制与治疗。
Clin Rheumatol. 2023 Oct;42(10):2601-2610. doi: 10.1007/s10067-022-06446-y. Epub 2022 Nov 17.
6
Prediction of Future Overt Pulmonary Hypertension by 6-Min Walk Stress Echocardiography in Patients With Connective Tissue Disease.结缔组织病患者 6 分钟步行应激超声心动图预测未来显性肺动脉高压。
J Am Coll Cardiol. 2015 Jul 28;66(4):376-84. doi: 10.1016/j.jacc.2015.05.032.
7
Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.右心房功能对结缔组织病相关肺动脉高压预后的预测价值:二维斑点追踪研究
Int J Cardiovasc Imaging. 2019 Sep;35(9):1637-1649. doi: 10.1007/s10554-019-01613-w. Epub 2019 Apr 29.
8
[Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].[1892例结缔组织病患者中79例肺动脉高压的临床分析]
Zhonghua Yi Xue Za Zhi. 2009 Nov 10;89(41):2934-7.
9
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.结缔组织病合并肺动脉高压患者的治疗策略和生存:COMPERA 分析。
Rheumatology (Oxford). 2024 Apr 2;63(4):1139-1146. doi: 10.1093/rheumatology/kead360.
10
Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.平均肺动脉压作为结缔组织病相关间质性肺疾病的预后指标:一项回顾性队列研究。
BMC Pulm Med. 2016 Apr 19;16(1):55. doi: 10.1186/s12890-016-0207-3.

引用本文的文献

1
[A clinical analysis of 15 children with systemic lupus erythematosus accompanied by pulmonary hypertension].15例系统性红斑狼疮伴肺动脉高压患儿的临床分析
Zhongguo Dang Dai Er Ke Za Zhi. 2017 Jun;19(6):658-662. doi: 10.7499/j.issn.1008-8830.2017.06.009.
2
Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations.儿童系统性红斑狼疮伴轻微疾病表现的亚临床肺动脉高压
Pediatr Cardiol. 2017 Feb;38(2):234-239. doi: 10.1007/s00246-016-1504-6. Epub 2016 Nov 8.

本文引用的文献

1
Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials.弥漫性系统性硬化症患者的性别和种族差异——来自三项大型随机临床试验的分析。
Rheumatology (Oxford). 2011 Feb;50(2):335-42. doi: 10.1093/rheumatology/keq294. Epub 2010 Oct 1.
2
Updated clinical classification of pulmonary hypertension.肺动脉高压的更新临床分类。
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-S54. doi: 10.1016/j.jacc.2009.04.012.
3
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.狼疮和混合性结缔组织病相关肺动脉高压的免疫抑制治疗:23例回顾性分析
Arthritis Rheum. 2008 Feb;58(2):521-31. doi: 10.1002/art.23303.
4
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.系统性硬化症中肺动脉高压的早期检测:一项法国全国性前瞻性多中心研究。
Arthritis Rheum. 2005 Dec;52(12):3792-800. doi: 10.1002/art.21433.
5
The endothelin system in pulmonary arterial hypertension.肺动脉高压中的内皮素系统。
Cardiovasc Res. 2004 Feb 1;61(2):227-37. doi: 10.1016/j.cardiores.2003.11.026.
6
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.系统性硬化症相关肺动脉高压的患病率及预后:登记方法的应用
Ann Rheum Dis. 2003 Nov;62(11):1088-93. doi: 10.1136/ard.62.11.1088.
7
Bosentan therapy for pulmonary arterial hypertension.波生坦治疗肺动脉高压
N Engl J Med. 2002 Mar 21;346(12):896-903. doi: 10.1056/NEJMoa012212.
8
Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.系统性红斑狼疮中的肺动脉高压:临床特征评估及对免疫抑制治疗的反应
J Rheumatol. 2002 Feb;29(2):282-7.
9
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.持续静脉输注依前列醇治疗硬皮病谱系疾病所致肺动脉高压:一项随机对照试验。
Ann Intern Med. 2000 Mar 21;132(6):425-34. doi: 10.7326/0003-4819-132-6-200003210-00002.
10
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.依前列醇治疗系统性红斑狼疮患者的肺动脉高压
Chest. 2000 Jan;117(1):14-8. doi: 10.1378/chest.117.1.14.